Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Net Sales Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Sales Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Net Sales Growth(%) 14.50-0.8556.29-17.6427.08

What is the latest Net Sales Growth ratio of GLAND PHARMA ?

The latest Net Sales Growth ratio of GLAND PHARMA is 14.50 based on Mar2026 Consolidated results.
Year Net Sales Growth
Mar202614.50
Mar2025-0.85
Mar202456.29
Mar2023-17.64
Mar202227.08

How is Net Sales Growth of GLAND PHARMA Trending?

Years Net Sales Growth % Change
Mar2026 14.5
Positive
Mar2025 -0.85
Negative
Mar2024 56.29
Positive
Mar2023 -17.64
Negative
Mar2022 27.08 -

Other Financial Ratios of GLAND PHARMA


Compare Net Sales Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹50,735.0 Cr 8.8% 6.2% 57.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8.8%

6.2%

57.7%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses